Stage IIIB non-small cell lung cancer (NSCLC) marks the beginning of metastasis and represents a critical turning point in terms of patient survival. Varying methods of treatment have led to an accumulation of knowledge that can be problematic for both doctors and patients to decipher when making crucial judgments regarding the efficacy of treatment options. This research examined current literature and various treatment options using a meta-analysis and an independent samples t-test to compare differences in median survival rates. Pertinent data published over a 20 year period encompassing 32,313 patients diagnosed with Stage IIIB NSCLC was summarized in this research. The studies tested in the meta-analysis of this data included varying sample sizes so weighting according to sample size was performed on all outcome measures. The results of the testing indicated that chemoradiotherapy produced the greatest median survival rate (14.13 months), radiation (11.04 months), chemotherapy (7.76 months), and palliative care (4.67 months) when treating patients diagnosed with Stage IIIB NSCLC. This research compiled and analyzed data from previous studies to assist patients and physicians in reaching succinct conclusions as to which treatment modality or combination of modalities is the best treatment for each individual diagnosed with Stage IIIB NSCLC. Additional immunotherapy studies, research trials focused specifically on Stage IIIB NSCLC, and further exploration into the field of genomics, would be desirable tactics to employ in combating this disease that still yields such a poor length of survival regardless of whatever treatment modality is chosen.
|School Location:||United States -- Arizona|
|Source:||DAI-B 72/04, Dissertation Abstracts International|
|Subjects:||Health care management, Oncology|
|Keywords:||Cancer survival, Chemotherapy, Lung cancer, Palliative care, Radiotherapy|
Copyright in each Dissertation and Thesis is retained by the author. All Rights Reserved
The supplemental file or files you are about to download were provided to ProQuest by the author as part of a
dissertation or thesis. The supplemental files are provided "AS IS" without warranty. ProQuest is not responsible for the
content, format or impact on the supplemental file(s) on our system. in some cases, the file type may be unknown or
may be a .exe file. We recommend caution as you open such files.
Copyright of the original materials contained in the supplemental file is retained by the author and your access to the
supplemental files is subject to the ProQuest Terms and Conditions of use.
Depending on the size of the file(s) you are downloading, the system may take some time to download them. Please be